Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Cell protective mechanism of valproic acid in lethal hemorrhagic shock.

Li Y, Liu B, Sailhamer EA, Yuan Z, Shults C, Velmahos GC, deMoya M, Shuja F, Butt MU, Alam HB.

Surgery. 2008 Aug;144(2):217-24. doi: 10.1016/j.surg.2008.03.037.

PMID:
18656628
2.

Pharmacologic resuscitation: cell protective mechanisms of histone deacetylase inhibition in lethal hemorrhagic shock.

Butt MU, Sailhamer EA, Li Y, Liu B, Shuja F, Velmahos GC, DeMoya M, King DR, Alam HB.

J Surg Res. 2009 Oct;156(2):290-6. doi: 10.1016/j.jss.2009.04.012. Epub 2009 May 13.

PMID:
19665733
3.

Hepatoprotection and lethality rescue by histone deacetylase inhibitor valproic acid in fatal hemorrhagic shock.

Gonzales ER, Chen H, Munuve RM, Mehrani T, Nadel A, Koustova E.

J Trauma. 2008 Sep;65(3):554-65. doi: 10.1097/TA.0b013e31818233ef.

PMID:
18784568
4.

Histone deacetylase inhibitors prevent apoptosis following lethal hemorrhagic shock in rodent kidney cells.

Zacharias N, Sailhamer EA, Li Y, Liu B, Butt MU, Shuja F, Velmahos GC, de Moya M, Alam HB.

Resuscitation. 2011 Jan;82(1):105-9. doi: 10.1016/j.resuscitation.2010.09.469. Epub 2010 Oct 30.

6.

Prevention of hypoxia-induced neuronal apoptosis through histone deacetylase inhibition.

Li Y, Yuan Z, Liu B, Sailhamer EA, Shults C, Velmahos GC, Demoya M, Alam HB.

J Trauma. 2008 Apr;64(4):863-70; discussion 870-1. doi: 10.1097/TA.0b013e318166b822.

PMID:
18404049
7.

Histone deacetylase as therapeutic target in a rodent model of hemorrhagic shock: effect of different resuscitation strategies on lung and liver.

Lin T, Chen H, Koustova E, Sailhamer EA, Li Y, Shults C, Liu B, Rhee P, Kirkpatrick J, Alam HB.

Surgery. 2007 Jun;141(6):784-94.

PMID:
17560255
8.

Valproic acid-mediated neuroprotection in intracerebral hemorrhage via histone deacetylase inhibition and transcriptional activation.

Sinn DI, Kim SJ, Chu K, Jung KH, Lee ST, Song EC, Kim JM, Park DK, Kun Lee S, Kim M, Roh JK.

Neurobiol Dis. 2007 May;26(2):464-72. Epub 2007 Feb 23.

PMID:
17398106
9.

Valproic acid prevents hemorrhage-associated lethality and affects the acetylation pattern of cardiac histones.

Gonzales E, Chen H, Munuve R, Mehrani T, Britten-Webb J, Nadel A, Alam HB, Wherry D, Burris D, Koustova E.

Shock. 2006 Apr;25(4):395-401.

PMID:
16670643
10.

Identification of a novel potential biomarker in a model of hemorrhagic shock and valproic acid treatment.

Li Y, Liu B, Dillon ST, Fukudome EY, Kheirbek T, Sailhamer EA, Velmahos G, deMoya M, Libermann TA, Alam HB.

J Surg Res. 2010 Mar;159(1):474-81. doi: 10.1016/j.jss.2009.04.011. Epub 2009 May 13.

PMID:
19765733
11.
12.
13.

Surviving blood loss without blood transfusion in a swine poly-trauma model.

Alam HB, Shuja F, Butt MU, Duggan M, Li Y, Zacharias N, Fukudome EY, Liu B, Demoya M, Velmahos GC.

Surgery. 2009 Aug;146(2):325-33. doi: 10.1016/j.surg.2009.04.007. Epub 2009 Jun 25.

PMID:
19628092
14.

Valproic acid-mediated myocardial protection of acute hemorrhagic rat via the BCL-2 pathway.

Wang C, Wang Y, Qiao Z, Kuai Q, Wang Y, Wang X, He M, Li W, He Y, Ren S, Yu Q.

J Trauma Acute Care Surg. 2016 May;80(5):812-8. doi: 10.1097/TA.0000000000000987.

PMID:
26886004
15.

Surviving blood loss without fluid resuscitation.

Shults C, Sailhamer EA, Li Y, Liu B, Tabbara M, Butt MU, Shuja F, Demoya M, Velmahos G, Alam HB.

J Trauma. 2008 Mar;64(3):629-38; discussion 638-40. doi: 10.1097/TA.0b013e3181650ff3.

PMID:
18332802
16.

Histone deacetylase inhibitors and candidate gene expression: An in vivo and in vitro approach to studying chromatin remodeling in a clinical population.

Gavin DP, Kartan S, Chase K, Jayaraman S, Sharma RP.

J Psychiatr Res. 2009 Jun;43(9):870-6. doi: 10.1016/j.jpsychires.2008.12.006. Epub 2009 Feb 1.

PMID:
19187942
17.

[The effects of administration of valproic acid on organ function and outcome in a canine lethal hemorrhagic shock model].

Hu S, Hou JY, Li L, Yang MX, Sheng ZY.

Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2011 Aug;23(8):471-4. Chinese.

18.

Additive effects of histone deacetylase inhibitors and amphetamine on histone H4 acetylation, cAMP responsive element binding protein phosphorylation and DeltaFosB expression in the striatum and locomotor sensitization in mice.

Shen HY, Kalda A, Yu L, Ferrara J, Zhu J, Chen JF.

Neuroscience. 2008 Dec 2;157(3):644-55. doi: 10.1016/j.neuroscience.2008.09.019. Epub 2008 Sep 16.

PMID:
18848971
19.

Histone deacetylase inhibitor valproic acid inhibits proliferation and induces apoptosis in KM3 cells via downregulating VEGF receptor.

Dong XF, Song Q, Li LZ, Zhao CL, Wang LQ.

Neuro Endocrinol Lett. 2007 Dec;28(6):775-80.

PMID:
18063935
20.

Valproic acid improves outcome after rodent spinal cord injury: potential roles of histone deacetylase inhibition.

Lv L, Sun Y, Han X, Xu CC, Tang YP, Dong Q.

Brain Res. 2011 Jun 17;1396:60-8. doi: 10.1016/j.brainres.2011.03.040. Epub 2011 Mar 22.

PMID:
21439269

Supplemental Content

Support Center